JB Medical Ltd, The Old Brickworks Chapel Lane, Sudbury, Suffolk, UK.
Aliment Pharmacol Ther. 2010 May;31(9):938-49. doi: 10.1111/j.1365-2036.2010.04273.x. Epub 2010 Feb 20.
BACKGROUND: Comparison of quality of life (QoL) across disease areas requires the use of appropriate tools. Although many studies have investigated QoL in constipation, most used disease-specific tools that are inappropriate for cross-comparisons. AIMS: To identify studies of QoL in constipation and to compare these results with other chronic conditions. METHODS: A comprehensive literature search identified studies in constipation that used a generic QoL tool. Results were statistically pooled where possible and compared with published results using the same tools in other chronic conditions. RESULTS: A total of 13 qualifying studies were identified, 10 in adults and three in children. Results from eight studies using the SF-36/12 tools were pooled; the remaining five were narratively reported. Mental and physical components of QoL scores were consistently impaired in both adult and child populations, with the greatest impact being seen in secondary care studies. Mental health effects predominated over physical domains. The magnitude of impact was comparable with that seen in patients with allergies, musculoskeletal conditions and inflammatory bowel disease. CONCLUSIONS: The impact of constipation on QoL is significant and comparable with other common chronic conditions. Improving management may prove to be an effective way of improving QoL for a substantial number of patients.
背景:比较不同疾病领域的生活质量(QoL)需要使用适当的工具。尽管许多研究已经调查了便秘的 QoL,但大多数研究使用的是特定于疾病的工具,不适合进行交叉比较。
目的:确定便秘患者 QoL 的研究,并将这些结果与其他慢性疾病进行比较。
方法:全面的文献检索确定了使用通用 QoL 工具的便秘研究。在可能的情况下,对结果进行了统计学汇总,并与使用相同工具在其他慢性疾病中发表的结果进行了比较。
结果:共确定了 13 项合格的研究,其中 10 项在成人中,3 项在儿童中。使用 SF-36/12 工具的八项研究的结果被汇总;其余五项以叙述性报告。在成年和儿童人群中,QoL 评分的心理和生理成分都受到了一致的损害,在二级保健研究中观察到的影响最大。心理健康影响超过了身体领域。其影响程度与过敏、肌肉骨骼疾病和炎症性肠病患者相似。
结论:便秘对 QoL 的影响是显著的,与其他常见的慢性疾病相当。改善管理可能被证明是改善大量患者 QoL 的有效方法。
Aliment Pharmacol Ther. 2010-2-20
Health Technol Assess. 2006-9
Health Technol Assess. 2024-10
Evid Rep Technol Assess (Full Rep). 2007-8
Cochrane Database Syst Rev. 2012-9-12
Cochrane Database Syst Rev. 2018-2-9
Cochrane Database Syst Rev. 2017-8-2
Cochrane Database Syst Rev. 2021-10-12
Cochrane Database Syst Rev. 2017-4-24
Cochrane Database Syst Rev. 2017-1-14
Front Med (Lausanne). 2025-7-9
Front Med (Lausanne). 2025-6-23
BMC Gastroenterol. 2025-7-1
Clin Gastroenterol Hepatol. 2025-5-20